Dr AUCAGNE Romain

Fiche personne


coordonnées

Inserm UMR 1231
Faculté de Médecine
7 bd Jeanne d'Arc
BP 87900
21079 DIJON Cedex

03 80 09 34 40

Aucagne.romain@gmail.com

Territoire

Bourgogne

Statut

Ingénieur/Technicien

Publications


MEK inhibition overcomes chemoimmunotherapy resistance by inducing CXCL10 in cancer cells.

Limagne E, Nuttin L, Thibaudin M, Jacquin E, Aucagne R, Bon M, Revy S, Barnestein R, Ballot E, Truntzer C, Derangère V, Fumet JD, Latour C, Rébé C, Bellaye PS, Kaderbhaï CG, Spill A, Collin B, Callanan MB, Lagrange A, Favier L, Coudert B, Arnould L, Ladoire S, Routy B, Joubert P, Ghiringhelli F

Cancer Cell. 2022 Jan 17;:

CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL.

Bouroumeau A, Bussot L, Hamaidia S, Garcìa-Sandoval A, Bergan-Dahl A, Betton-Fraisse P, Duley S, Fournier C, Aucagne R, Adrait A, Couté Y, McLeer A, Col E, David-Boudet L, Raskovalova T, Jacob MC, Vettier C, Chevalier S, Carras S, Lefebvre C, Algrin C, Gressin R, Callanan MB, Sartelet H, Bonnefoix T, Emadali A

Cancers (Basel). 2021 Nov 24;13(23):

Identification of novel, clonally stable, somatic mutations targeting transcription factors PAX5 and NKX2-3, the epigenetic regulator LRIF1, and BRAF in a case of atypical B-cell chronic lymphocytic leukemia harboring a t(14;18)(q32;q21).

Burlet B, Ramla S, Fournier C, Abrey-Recalde MJ, Sauter C, Chrétien ML, Rossi C, Duffourd Y, Ragot S, Buriller C, Tournier B, Chapusot C, Nadal N, Racine J, Guy J, Bailly F, Martin L, Casasnovas O, Bastie JN, Caillot D, Albuisson J, Broccardo C, Thieblemont C, Delva L, Maynadié M, Aucagne R, Callanan MB

Cold Spring Harb Mol Case Stud. 2021 Feb;7(1):

Voir plus